UNSPSC 51285318: Nifurvidine

This classification denotes an anti-infective agent with the molecular formula C11H9N3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y0G95D5K2W, chemically known as 4-pyrimidinol, 2-methyl-6-(2-(5-nitro-2-furyl)vinyl)- but more generally known as nifurvidine, which bears US NIH Compound Identifier 6441378. European Medicines Agency schedules Nifurvidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09282MIG. The term NIFURVIDINE is an International Non-Proprietary Name.

UNSPSC 51285318 Nifurvidine is a Commodity code that, based on recent state and local solicitations, encompasses pharmaceuticals and related health supplies procured by county health departments, municipal fire departments, and multistate cooperative purchasing alliances. The recent opportunities under this code show state and local governments buying naloxone and drug deactivation systems for community health initiatives, medical and first aid supplies for emergency response divisions, and generic pharmaceuticals distributed through authorized wholesalers to government health facilities. Issuing bodies include county health departments (Seminole County, Florida), city fire departments (City of Tampa), state health agencies (Texas Health and Human Services Commission), and multistate cooperative purchasing vehicles (Minnesota Multistate Cooperative Purchasing Alliance serving Minnesota, Oregon, and other member jurisdictions). The mix reflects both single-jurisdiction procurements and regional cooperative arrangements that aggregate demand across multiple states and local government entities.

Geographic activity centers on Florida, Texas, and the Upper Midwest, with the Minnesota cooperative arrangement spanning multiple states including Oregon. Representative recent opportunities include Seminole County's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) soliciting 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries; the City of Tampa's IFB 26P00145 (posted March 25, 2026, due March 13, 2026) seeking 169 line items of medical and first aid supplies for its Fire Department Rescue Division with an estimated contract value of $700,000 and a sheltered-market set-aside for certified Small Local Business Enterprises; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products through authorized wholesalers, with contract effectiveness July 1, 2026. The Texas Health and Human Services Commission's RFI HHS0017013 (posted April 3, 2026) represents preliminary market intelligence gathering for a direct-to-manufacturer prescription program rather than a formal competitive solicitation.